Top

Published in:

01-07-2015 | Preeclampsia (VD Garovic, Section Editor)

Secondary Hypertension in Pregnancy

Authors: Line Malha, Phyllis August

Published in: Current Hypertension Reports | Issue 7/2015

Abstract

Hypertension is a common medical complication of pregnancy. Although 75–80 % of women with preexisting essential hypertension will have uncomplicated pregnancies, the presence of secondary forms of hypertension adds considerably to both maternal and fetal morbidity and mortality. Renovascular hypertension, pheochromocytoma, and Cushing’s syndrome in particular are associated with accelerating hypertension, superimposed preeclampsia, preterm delivery, and fetal loss. Primary aldosteronism is a more heterogeneous disorder; there are well-documented cases where blood pressure and hypokalemia are improved during pregnancy due to elevated levels of progesterone. However, superimposed preeclampsia, worsening hypertension, and early delivery are also reported. When possible, secondary forms of hypertension should be diagnosed and treated prior to conception in order to avoid these complications.

1.•

Barton JR, O'Brien JM, Bergauer NK, Jacques DL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol. 2001;184(5):979–83. doi:10.1067/mob.2001.112905. A very large observational study reporting the incidence of chronic hypertension in pregnancy over the span of 7 years and its effect on pregnancy outcomes. It also gives differential impact of primary and secondary causes of chronic hypertension.PubMedCrossRef

Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012;206(2):134 e1–8. doi:10.1016/j.ajog.2011.10.878.CrossRef

Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension. 2014;64(1):36–44. doi:10.1161/hypertensionaha.113.02766.PubMedCentralPubMedCrossRef

Yucesoy G, Ozkan S, Bodur H, Tan T, Caliskan E, Vural B, et al. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet. 2005;273(1):43–9. doi:10.1007/s00404-005-0741-3.PubMedCrossRef

Zugna D, Galassi C, Annesi-Maesano I, Baiz N, Barros H, Basterrechea M, et al. Maternal complications in pregnancy and wheezing in early childhood: a pooled analysis of 14 birth cohorts. Int J Epidemiol. 2015;44(1):199–208. doi:10.1093/ije/dyu260.PubMedCrossRef

6.•

Leffert LR, Clancy CR, Bateman BT, Bryant AS, Kuklina EV. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol. 2015;125(1):124–31. doi:10.1097/aog.0000000000000590. A very large observational study reporting higher risk for pregnant women with hypertension to have a stroke in the year 2010–2011 as compared to 1994–1995 despite all other advances in the medical field over the past 15 years.PubMedCentralPubMedCrossRef

Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299–306. doi:10.1097/AOG.0b013e3181a45b25.PubMedCrossRef

Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS ONE. 2014;9(6):e100180. doi:10.1371/journal.pone.0100180.PubMedCentralPubMedCrossRef

9.••

American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(1122–31):1122–31. doi:10.1097/01.aog.0000437382.03963.88. Guidelines for the treatment of hypertension in pregnancy, they are the main reference for clinicians.

10.

11.

Hussain A, Karovitch A, Carson MP. Blood pressure goals and treatment in pregnant patients with chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(2):165–9. doi:10.1053/j.ackd.2014.08.002.PubMedCrossRef

12.

Dugas G, Fuller J, Singh S, Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. J Can Anesth. 2004;51(2):134–8. doi:10.1007/bf03018772.CrossRef

13.

Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg. 1999;23(2):182–6.PubMedCrossRef

14.

Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg. 2013;100(2):182–90. doi:10.1002/bjs.8976.PubMedCrossRef

15.

Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocr Pract : Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2010;16(2):300–9. doi:10.4158/ep09191.ra.CrossRef

16.

Oliva R, Angelos P, Kaplan E, Bakris G. Pheochromocytoma in pregnancy: a case series and review. Hypertension. 2010;55(3):600–6. doi:10.1161/hypertensionaha.109.147579.PubMedCrossRef

17.

Harper MA, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB. Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol. 1989;96(5):594–606.PubMedCrossRef

18.

Ellison GT, Mansberger JA, Mansberger Jr AR. Malignant recurrent pheochromocytoma during pregnancy: case report and review of the literature. Surgery. 1988;103(4):484–9.PubMed

19.

Hudsmith JG, Thomas CE, Browne DA. Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. Int J Obstet Anesth. 2006;15(3):240–5. doi:10.1016/j.ijoa.2005.11.003.PubMedCrossRef

20.

Kudva YC, Sawka AM, Young Jr WF. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003;88(10):4533–9. doi:10.1210/jc.2003-030720.PubMedCrossRef

21.

Kamari Y, Sharabi Y, Leiba A, Peleg E, Apter S, Grossman E. Peripartum hypertension from pheochromocytoma: a rare and challenging entity. Am J Hypertens. 2005;18(10):1306–12. doi:10.1016/j.amjhyper.2005.04.021.PubMedCrossRef

22.

Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med. 2000;160(16):2521–4.PubMedCrossRef

23.

Takongmo S, Wawo Yonta E, Gonsu Kamga H, Ngongang J, Simo-Moyo J, Essame Oyono JL, et al. Diagnosis of pheochromocytoma in Yaounde (Cameroon): a study of nine cases. Med Trop (Mars). 2010;70(3):274–6.

24.

Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–66. doi:10.1056/NEJMoa020152.PubMedCrossRef

25.

Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv. 1999;54(11):728–37.PubMedCrossRef

26.

Carty D, Crichton L, Alakandy L, O'Dwyer P, Dominiczak A. Hypertension in pregnancy: think laterally. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):220–1. doi:10.1016/j.ejogrb.2010.03.005.PubMedCrossRef

27.

Wu JC, Wu HS, Lin MS, Chou DA, Huang MH. Comparison of robot-assisted laparoscopic adrenalectomy with traditional laparoscopic adrenalectomy—1 year follow-up. Surg Endosc. 2008;22(2):463–6. doi:10.1007/s00464-007-9488-1.PubMedCrossRef

28.

Brunaud L, Bresler L, Ayav A, Zarnegar R, Raphoz AL, Levan T, et al. Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy? Am J Surg. 2008;195(4):433–8. doi:10.1016/j.amjsurg.2007.04.016.PubMedCrossRef

29.

Kim PT, Kreisman SH, Vaughn R, Panton ON. Laparoscopic adrenalectomy for pheochromocytoma in pregnancy. Can J Surg J Can Chir. 2006;49(1):62–3.

30.

Song Y, Liu J, Li H, Zeng Z, Bian X, Wang S. Outcomes of concurrent Caesarean delivery and pheochromocytoma resection in late pregnancy. Int Med J. 2013;43(5):588–91. doi:10.1111/imj.12118.CrossRef

31.

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–300. doi:10.1016/j.jacc.2006.07.059.PubMedCrossRef

32.

Riester A, Fischer E, Degenhart C, Reiser MF, Bidlingmaier M, Beuschlein F, et al. Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab. 2014;99(6):E1035–9. doi:10.1210/jc.2013-3789.PubMedCrossRef

33.

Rossi GP, Lenzini L. Primary aldosteronism: molecular mechanisms and diagnosis. 2014.

34.

Westerdahl C, Bergenfelz A, Isaksson A, Nerbrand C, Valdemarsson S. Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care. 2011;29(1):57–62. doi:10.3109/02813432.2011.554015.PubMedCentralPubMed

35.•

Riester A, Reincke M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol / Eur Fed Endoc Soc. 2015;172(1):R23–30. doi:10.1530/eje-14-0444. This is a thorough review of the literature and insightful description of the diagnosis and management of primary aldosteronism in pregnancy.CrossRef

36.

Rossi GP. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep. 2004;6(1):1–4.PubMedCrossRef

37.

Biglieri EG, Slaton Jr PE. Pregnancy and primary aldosteronism. J Clin Endocrinol Metab. 1967;27(11):1628–32. doi:10.1210/jcem-27-11-1628.PubMedCrossRef

38.

Brown MA, Sinosich MJ, Saunders DM, Gallery ED. Potassium regulation and progesterone-aldosterone interrelationships in human pregnancy: a prospective study. Am J Obstet Gynecol. 1986;155(2):349–53.PubMedCrossRef

39.

Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol. 2002;19(1):31–6. doi:10.1055/s-2002-20170.PubMedCrossRef

40.

August PJ, A. Roberts J. M. In: Taylor RNR, J.M.; Cunningham, F.G.; Lindheimer, M.D., editor. Chesley’s hypertensive disorders in pregnancy. 4th ed.: Academic Press/Elsevier; 2015.

41.

Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney Dis. 2007;14(2):178–90. doi:10.1053/j.ackd.2007.01.008.PubMedCrossRef

42.

Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension. 2000;35(2):668–72.PubMedCrossRef

43.

Kosaka K, Onoda N, Ishikawa T, Iwanaga N, Yamamasu S, Tahara H, et al. Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy. Endocr J. 2006;53(4):461–6.PubMedCrossRef

44.

Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh). 1980;95(4):540–5.

45.

Caretto A, Primerano L, Novara F, Zuffardi O, Genovese S, Rondinelli M. A therapeutic challenge: Liddle’s syndrome managed with amiloride during pregnancy. Case Rep Obstet Gynecol. 2014;2014:156250. doi:10.1155/2014/156250.PubMedCentralPubMed

46.

Al-Ali NA, El-Sandabesee D, Steel SA, Roland JM. Conn’s syndrome in pregnancy successfully treated with amiloride. J Obstet Gynaecol : J Inst Obstet Gynaecol. 2007;27(7):730–1. doi:10.1080/01443610701667098.CrossRef

47.

Dietz JD, Du S, Bolten CW, Payne MA, Xia C, Blinn JR, et al. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension. 2008;51(3):742–8. doi:10.1161/hypertensionaha.107.103580.PubMedCrossRef

48.

Baron F, Sprauve ME, Huddleston JF, Fisher AJ. Diagnosis and surgical treatment of primary aldosteronism in pregnancy: a case report. Obstet Gynecol. 1995;86(4 Pt 2):644–5.PubMedCrossRef

49.

Solomon CG, Thiet M, Moore Jr F, Seely EW. Primary hyperaldosteronism in pregnancy. A case report. J Reprod Med. 1996;41(4):255–8.PubMed

50.

Shalhav AL, Landman J, Afane J, Levi R, Clayman RV. Laparoscopic adrenalectomy for primary hyperaldosteronism during pregnancy. J Laparoendosc Adv Surg Tech Part A. 2000;10(3):169–71.CrossRef

51.

Sahota PK, Jain SS, Dhand R. Sleep disorders in pregnancy. Curr Opin Pulm Med. 2003;9(6):477–83.PubMedCrossRef

52.

Pilkington S, Carli F, Dakin MJ, Romney M, De Witt KA, Dore CJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth. 1995;74(6):638–42.PubMedCrossRef

53.

Antony KM, Agrawal A, Arndt ME, Murphy AM, Alapat PM, Guntupalli KK, et al. Obstructive sleep apnea in pregnancy: reliability of prevalence and prediction estimates. J Perinatol : off J Calif Perinat Assoc. 2014;34(8):587–93. doi:10.1038/jp.2014.48.CrossRef

54.•

O'Brien LM, Bullough AS, Chames MC, Shelgikar AV, Armitage R, Guilleminualt C, et al. Hypertension, snoring, and obstructive sleep apnoea during pregnancy: a cohort study. BJOG : Int J Obstet Gynaecol. 2014;121(13):1685–93. doi:10.1111/1471-0528.12885. This study established the incidence of OSA in pregnancy across different etiology of hypertension and in non-hypertensives. It also recognizes that snoring may be an important symptom and is associated with OSA.CrossRef

55.

Pien GW, Pack AI, Jackson N, Maislin G, Macones GA, Schwab RJ. Risk factors for sleep-disordered breathing in pregnancy. Thorax. 2014;69(4):371–7. doi:10.1136/thoraxjnl-2012-202718.PubMedCrossRef

56.

Reid J, Glew RA, Skomro R, Fenton M, Cotton D, Olatunbosun F, et al. Sleep disordered breathing and gestational hypertension: postpartum follow-up study. Sleep. 2013;36(5):717–21b. doi:10.5665/sleep.2634.PubMedCentralPubMed

57.

Facco FL, Ouyang DW, Zee PC, Grobman WA. Development of a pregnancy-specific screening tool for sleep apnea. J Clin Sleep Med : JCSM : Off Publ Am Acad Sleep Med. 2012;8(4):389–94. doi:10.5664/jcsm.2030.

58.

Louis J, Auckley D, Miladinovic B, Shepherd A, Mencin P, Kumar D, et al. Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol. 2012;120(5):1085–92. doi:10.1097/AOG.0b013e31826eb9d8.PubMed

59.

Louis JM, Auckley D, Sokol RJ, Mercer BM. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol. 2010;202(3):261 e1–5. doi:10.1016/j.ajog.2009.10.867.CrossRef

60.

Pengo MF, Rossi GP, Steier J. Obstructive sleep apnea, gestational hypertension and preeclampsia: a review of the literature. Curr Opin Pulm Med. 2014;20(6):588–94. doi:10.1097/mcp.0000000000000097.PubMedCrossRef

61.

Reichmann JP. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol. 2013;208(6):507. doi:10.1016/j.ajog.2013.01.029.PubMedCrossRef

62.

Chen YH, Kang JH, Lin CC, Wang IT, Keller JJ, Lin HC. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol. 2012;206(2):136 e1–5. doi:10.1016/j.ajog.2011.09.006.CrossRef

63.

Sahin FK, Koken G, Cosar E, Saylan F, Fidan F, Yilmazer M, et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet. 2008;100(2):141–6. doi:10.1016/j.ijgo.2007.08.012.CrossRef

64.

Olivarez SA, Maheshwari B, McCarthy M, Zacharias N, van den Veyver I, Casturi L, et al. Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol. 2010;202(6):552 e1–7. doi:10.1016/j.ajog.2009.12.008.CrossRef

65.•

Whitehead C, Tong S, Wilson D, Howard M, Walker SP. Treatment of early-onset preeclampsia with continuous positive airway pressure. Obstet Gynecol. 2015. doi:10.1097/aog.0000000000000508. This article supports the use of CPAP in pregnancy by showing this therapy is effective in women with pre-eclampsia and sleep-disordered breathing.

66.

Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep. 2004;27(1):79–84.PubMed

67.

Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med. 2000;162(1):252–7. doi:10.1164/ajrccm.162.1.9905006.PubMedCrossRef

68.

Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78. doi:10.1161/01.cir.0000442577.96802.8c.PubMedCrossRef

69.

Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90. doi:10.1161/circulationaha.112.091223.PubMedCrossRef

70.

Thorsteinsdottir B, Kane GC, Hogan MJ, Watson WJ, Grande JP, Garovic VD. Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract Nephrol. 2006;2(11):651–6. doi:10.1038/ncpneph0310.PubMedCrossRef

71.

Levin A, Linas S, Luft FC, Chapman AB, Textor S. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007;27(2):212–20. doi:10.1159/000101000.PubMedCrossRef

72.

Sellars L, Siamopoulos K, Wilkinson R. Prognosis for pregnancy after correction of renovascular hypertension. Nephron. 1985;39(3):280–1.PubMedCrossRef

73.

Hotchkiss RL, Nettles JB, Wells DE. Renovascular hypertension in pregnancy. South Med J. 1971;64(10):1256–8.PubMedCrossRef

74.

Polli N, Pecori Giraldi F, Cavagnini F. Cushing’s disease and pregnancy. Pituitary. 2004;7(4):237–41. doi:10.1007/s11102-005-1479-4.PubMedCrossRef

75.

Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH, Luton JP. Cushing’s syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med. 1992;1(2):83–9.PubMed

76.

Aron DC, Schnall AM, Sheeler LR. Cushing’s syndrome and pregnancy. Am J Obstet Gynecol. 1990;162(1):244–52.PubMedCrossRef

77.

Lubin V, Gautier JF, Antoine JM, Beressi JP, Vexiau P. Cushing’s syndrome during pregnancy. Presse Med (Paris, France : 1983). 2002;31(36):1706–13.

78.

Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab. 2005;90(5):3077–83. doi:10.1210/jc.2004-2361.PubMedCrossRef

79.

Sheeler LR. Cushing’s syndrome and pregnancy. Endocrinol Metab Clin N Am. 1994;23(3):619–27.

Title: Secondary Hypertension in Pregnancy
Authors: Line Malha
Phyllis August
Publication date: 01-07-2015
Publisher: Springer US
Published in: Current Hypertension Reports / Issue 7/2015
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-015-0563-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2015

Endothelin Receptor Antagonists: New Hope for Renal Protection?

Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders

Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?

Benefit of Blood Pressure Control in Diabetic Patients

Antihypertensive Combination Treatment: State of the Art

Blood Pressure in Older Adults: the Importance of Frailty

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage